Acknowledgements
We thank Dr. Elina Henkes and Dr. Philipp von Gottberg as well as Prof. Dr. Martina Deckert and Prof. Dr. Falko Fend and for their cooperation. Furthermore, we acknowledge the DMC members (Prof. Dr. Gerhard Held, Prof. Dr. Eva Hoster and Prof. Dr. Peter Hau) for their advisory opinion as well as the “Deutsche Leukämie- & Lymphom-Hilfe e.V. (DLH)” represented by managing director Dr. Ulrike Holtkamp, and chairman and patient representative Rainer Göbel.